Internet Archive Scholar

Cenobamate—The New Kid on the Block, Teaching More About Epilepsy Than Just Offering a New Treatment for Seizures

Roy G Beran, University of New South Wales, Sydney, New South Wales, Australia, School of Medicine, Griffith University, Queensland, Australia, Sechenov First Moscow State Medical University, Moscow, Russia
2020 US Neurology  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (60.5 kB)
https://web.archive.org/web/20210128213159/https://touchneurology.com/wp-content/uploads/sites/3/2020/12/touchNEURO_US_16.2_p85-86-1.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

T he treatment of epilepsy is evolving, and with it, so should our approach to treatment. A recent article by Klein et al. (published in this issue of US Neurology) confronted my own attitude towards anti-epileptic medication, and ultimately changed the way I view this therapy and the nomenclature I use. Their empathetic approach to the topic of new anti-seizure medication compelled me to write something that is normally outside of my usual remit. I hope this first-person perspective reflects
more » ... e impact this article had on me and encourages others to consider their own philosophy in this field.
doi:10.17925/usn.2020.16.2.85 fatcat:rb3nkawrg5bd7pbt3m63wmgb6m
Open Access
Citation

Roy G Beran, University of New South Wales, Sydney, New South Wales, Australia, School of Medicine, Griffith University, Queensland, Australia, Sechenov First Moscow State Medical University, Moscow, Russia. "Cenobamate—The New Kid on the Block, Teaching More About Epilepsy Than Just Offering a New Treatment for Seizures." US Neurology (2020) 85